NDA expected to be filed 1Q2010
Brand N/A Generic liprotamase (formerly known as ALTU-135 and Trizytek)
Company name Alnara Product type Speciality
Therapeutic category Enzyme Replacements and Modifiers Key uses cystic fibrosis, pancreatic insufficiency
Other Uses N/A Drug Class enzyme replacement therapy, non-porcine derived
Dosage From oral Expected Approval 2011-Q1
FDA Filing N/A Last Update date March 02,2010
Link to pipeline report
Link to news article
Link to clinicaltrials.gov